Former First Daughter Chelsea Clinton sits on the board of a multi-billion dollar insurance company called Clover Health — but you wouldn’t know it from the media reports.

The company faced a serious scandal in February, and its stock price tumbled.

Since then, Clover Health has rebuilt its reputation. The stock price has stabilized on the Nasdaq exchange. And Chelsea Clinton’s position on the board remains secure.

Did you hear anything about it? No, of course not.

The media was too busy gloating over the exact same issue plaguing Trump Media & Technology Group this fall.

Former President Donald Trump inspired several splashy headlines on Tuesday after the Securities and Exchange Commission requested additional information for his social media company’s filings. Even before that, Trump’s company got a concerned letter from Sen. Elizabeth Warren and an allegation of possible fraud in The New York Times.

Chelsea Clinton’s company behaved just like Trump Media… and it has gone almost completely unnoticed.

Clover Heath came under federal investigation for fraud earlier this year, according to a February report by the investment firm Hindenburg Research LLC.

The SEC asked Clover Health for some additional documentation… just as it did for Trump Media.

What’s more, Clover Heath failed to disclose this investigation to its investors. Then, it defended its lack of transparency. A company spokesperson wrote on Medium in February, “DOJ’s request for information was not material and was not required to be specifically disclosed.”

Now, Trump Media is attracting media attacks, and Clover Health is experiencing a healthy recovery on the stock market.

In June, the Washington Free Beacon requested comment from Clinton, the SEC, and the Department of Justice.

It received no responses.

 

Flashback: Elizabeth Warren targets Trump Media

 

The Horn editorial team